Advances in the diagnosis of pleural disease in lung cancer

Therapeutic Advances in Respiratory Disease

Volumn 5, Issue 6, 2011, Pages 409-418

  See, Kay Choong ^a   Lee, Pyng ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

biomarkers; imaging; lung cancer; pleural effusion; pleuroscopy

Indexed keywords

ANTINEOPLASTIC AGENT;

AUTOFLUORESCENCE THORACOSCOPY; CANCER CHEMOTHERAPY; CANCER INVASION; COMPUTER ASSISTED TOMOGRAPHY; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; HUMAN; LUNG BIOPSY; LUNG CANCER; LUNG CARCINOMA; NARROW BAND IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; PLEURA DISEASE; PLEUROSCOPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; THORACOSCOPY; ULTRASOUND;

ALGORITHMS; HUMANS; LUNG NEOPLASMS; MAGNETIC RESONANCE IMAGING; PLEURAL DISEASES; PLEURAL EFFUSION; PLEURAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; THORACOSCOPY;

EID: 83455258005     PISSN: 17534658     EISSN: 17534666     Source Type: Journal    
DOI: 10.1177/1753465811408637     Document Type: Review

References (63)

1. Abouzgheib W. Bartter T. Dagher H. Pratter M. Klump W. (2009) A prospective study of the volume of pleural fluid required for accurate diagnosis of malignant pleural effusion. Chest 135: 999–1001.
2. Aokage K. Yoshida J. Ishii G. Enatsu S. Hishida T. Nishimura M. (2010) The impact on survival of positive intraoperative pleural lavage cytology in patients with non-small-cell lung cancer. J Thorac Cardiovasc Surg 139: 1246–1252.
3. Baas P. Triesscheijn M. Burgers S. van Pel R. Stewart F. Aalders M. (2006) Fluorescence detection of pleural malignancies using 5-aminolaevulinic acid. Chest 129: 718–724.
4. Bielsa S. Esquerda A. Salud A. Montes A. Arellano E. Rodriguez-Panadero F. (2009) High levels of tumor markers in pleural fluid correlate with poor survival in patients with adenocarcinomatous or squamous malignant effusions. Eur J Intern Med 20: 383–386.
5. Chian C.F. Su W.L. Soh L.H. Yan H.C. Perng W.C. Wu C.P. (2004) Echogenic swirling pattern as a predictor of malignant pleural effusions in patients with malignancies. Chest 126: 129–134.
6. Chrysanthidis M.G. Janssen J.P. (2005) Autofluorescence videothoracoscopy in exudative pleural effusions: preliminary results. Eur Respir J 26: 989–992.
7. Chu A.Y. Litzky L.A. Pasha T.L. Acs G. Zhang P.J. (2005) Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant mesothelioma. Mod Pathol 18: 105–110.
8. Diacon A.H. Schuurmans M.M. Theron J. Schubert P.T. Wright C.A. Bolliger C.T. (2004) Safety and yield of ultrasound-assisted transthoracic biopsy performed by pulmonologists. Respiration 71: 519–522.
9. Enatsu S. Yoshida J. Yokose T. Nishimura M. Nishiwaki Y. Shirakusa T. (2006) Pleural lavage cytology before and after lung resection in non-small cell lung cancer patients. Ann Thorac Surg 81: 298–304.
10. Fischer B.M. Mortensen J. Hansen H. Vilmann P. Larsen S.S. Loft A. (2011) Multimodality approach to mediastinal staging in non-small cell lung cancer. Faults and benefits of PET-CT: a randomised trial. Thorax 66: 294–300.
11. Gill R.R. Umeoka S. Mamata H. Tilleman T.R. Stanwell P. Woodhams R. (2010) Diffusion-weighted MRI of malignant pleural mesothelioma: preliminary assessment of apparent diffusion coefficient in histologic subtypes. AJR Am J Roentgenol 195: W125–W130.
12. Gorg C. Bert T. Kring R. Dempfle A. (2006) Transcutaneous contrast enhanced sonography of the chest for evaluation of pleural based pulmonary lesions: experience in 137 patients. Ultraschall Med 27: 437–444.
13. Hanna A. Pang Y. Bedrossian C.W. Dejmek A. Michael C.W. (2010) Podoplanin is a useful marker for identifying mesothelioma in malignant effusions. Diagn Cytopathol 38: 264–269.
14. Havelock T. Teoh R. Laws D. Gleeson F. (2010) Pleural procedures and thoracic ultrasound: British Thoracic Society pleural disease guideline 2010. Thorax 65(Suppl. 2): ii61–ii76.
15. Heelan R.T. Demas B.E. Caravelli J.F. Martini N. Bains M.S. McCormack P.M. (1989) Superior sulcus tumors: CT and MR imaging. Radiology 170: 637–641.
16. Hersh C.P. Feller-Kopman D. Wahidi M. Garland R. Herth F. Ernst A. (2003) Ultrasound guidance for medical thoracoscopy: a novel approach. Respiration 70: 299–301.
17. Ho C.C. Liao W.Y. Wang C.Y. Lu Y.H. Huang H.Y. Chen H.Y. (2008) TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer. Am J Respir Crit Care Med 177: 763–770.
18. Hooper C. Lee Y.C. Maskell N. (2010) Investigation of a unilateral pleural effusion in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 65(Suppl. 2): ii4–ii17.
19. Horn M. Oechsner M. Gardarsdottir M. Kostler H. Muller M.F. (2010) Dynamic contrast-enhanced MR imaging for differentiation of rounded atelectasis from neoplasm. J Magn Reson Imaging 31: 1364–1370.
20. Hsu I.L. Su W.C. Yan J.J. Chang J.M. Lai W.W. (2009) Angiogenetic biomarkers in non-small cell lung cancer with malignant pleural effusion: correlations with patient survival and pleural effusion control. Lung Cancer 65: 371–376.
21. Huang W.W. Tsao S.M. Lai C.L. Su C.C. Tseng C.E. (2010) Diagnostic value of Her-2/neu, Cyfra 21-1, and carcinoembryonic antigen levels in malignant pleural effusions of lung adenocarcinoma. Pathology 42: 224–228.
22. Ishida A. Ishikawa F. Nakamura M. Miyazu Y.M. Mineshita M. Kurimoto N. (2009) Narrow band imaging applied to pleuroscopy for the assessment of vascular patterns of the pleura. Respiration 78: 432–439.
23. Kajiwara N. Akata S. Uchida O. Usuda J. Ohira T. Kawate N. (2010) Cine MRI enables better therapeutic planning than CT in cases of possible lung cancer chest wall invasion. Lung Cancer 69: 203–208.
24. Khambata-Ford S. Harbison C.T. Hart L.L. Awad M. Xu L.A. Horak C.E. (2010) Analysis of potential predictive markers of cetuximab benefit in BMS099, a phase III study of cetuximab and first-line taxane/carboplatin in advanced non-small-cell lung cancer. J Clin Oncol 28: 918–927.
25. Kim J.H. Choi Y.D. Lee J.S. Lee J.H. Nam J.H. Choi C. (2010) Utility of thyroid transcription factor-1 and CDX-2 in determining the primary site of metastatic adenocarcinomas in serous effusions. Acta Cytol 54: 277–282.
26. Kligerman S. Digumarthy S. (2009) Staging of non'small cell lung cancer using integrated PET/CT. AJR Am J Roentgenol 193: 1203–1211.
27. Koegelenberg C.F. Bolliger C.T. Theron J. Walzl G. Wright C.A. Louw M. (2010) Direct comparison of the diagnostic yield of ultrasound-assisted Abrams and Tru-Cut needle biopsies for pleural tuberculosis. Thorax 65: 857–862.
28. Lee P. Colt H.G. (2005) Rigid and semi-rigid pleuroscopy: the future is bright. Respirology 10: 418–425.
29. Lee P. Hsu A. Lo C. Colt H.G. (2007) Prospective evaluation of flex–rigid pleuroscopy for indeterminate pleural effusion: accuracy, safety and outcome. Respirology 12: 881–886.
30. Lee P. Mathur P.N. Colt H.G. (2010) Advances in thoracoscopy: 100 years since Jacobaeus. Respiration 79: 177–186.
31. Leung A.N. Mueller N.L. Miller R.R. (1990) CT in differential diagnosis of diffuse pleural disease. AJR Am J Roentgenol 154: 487–492.
32. Li H. Fu J. Xiu Y. Zhou Q. (2010) [Diagnostic significance of combining telomerase activity with CYFRA21-1 level in differentiating malignant pleural effusion caused by lung cancer from benign pleural effusion]. Zhongguo Fei Ai Za Zhi 13: 652–654.
33. Li W. Ni Y. Tu Z. Wu S. Wu Z. Zheng S. (2009) Study of telomerase activity in pleural lavage fluid specimens in patients with non-small-cell lung cancer and its clinical significance. Eur J Cardiothorac Surg 36: 460–464.
34. Lim E. Clough R. Goldstraw P. Edmonds L. Aokage K. Yoshida J. (2010) Impact of positive pleural lavage cytology on survival in patients having lung resection for non-small-cell lung cancer: An international individual patient data meta-analysis. J Thorac Cardiovasc Surg 139: 1441–1446.
35. Maskell N.A. Gleeson F.V. Davies R.J. (2003) Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial. Lancet 361: 1326–1330.
36. Munavvar M. Khan M.A. Edwards J. Waqaruddin Z. Mills J. (2007) The autoclavable semi-rigid thoracoscope: the way forward in pleural disease?. Eur Respir J 29: 571–574.
37. Padgett D.M. Cathro H.P. Wick M.R. Mills S.E. (2008) Podoplanin is a better immunohistochemical marker for sarcomatoid mesothelioma than calretinin. Am J Surg Pathol 32: 123–127.
38. Pu R.T. Giordano T.J. Michael C.W. (2008a) Utility of cytology microarray constructed from effusion cell blocks for immunomarker validation. Cancer 114: 300–306.
39. Pu R.T. Pang Y. Michael C.W. (2008b) Utility of WT-1, p63, MOC31, mesothelin, and cytokeratin (K903 and CK5/6) immunostains in differentiating adenocarcinoma, squamous cell carcinoma, and malignant mesothelioma in effusions. Diagn Cytopathol 36: 20–25.
40. Qureshi N.R. Rahman N.M. Gleeson F.V. (2009) Thoracic ultrasound in the diagnosis of malignant pleural effusion. Thorax 64: 139–143.
41. Rahman N.M. Ali N.J. Brown G. Chapman S.J. Davies R.J. Downer N.J. (2010) Local anaesthetic thoracoscopy: British Thoracic Society Pleural Disease Guideline 2010. Thorax 65(Suppl. 2): ii54–ii60.
42. Rami-Porta R. Crowley J.J. Goldstraw P. (2009) The revised TNM staging system for lung cancer. Ann Thorac Cardiovasc Surg 15: 4–9.
43. Roberts M.E. Neville E. Berrisford R.G. Antunes G. Ali N.J. (2010) Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax 65(Suppl. 2): ii32–ii40.
44. Sales R.K. Vargas F.S. Capelozzi V.L. Seiscento M. Genofre E.H. Teixeira L.R. (2009) Predictive models for diagnosis of pleural effusions secondary to tuberculosis or cancer. Respirology 14: 1128–1133.
45. Sasada S. Kawahara K. Kusunoki Y. Okamoto N. Iwasaki T. Suzuki H. (2009) A new electrocautery pleural biopsy technique using an insulated-tip diathermic knife during semirigid pleuroscopy. Surg Endosc 23: 1901–1907.
46. Satoh Y. Hoshi R. Ishikawa Y. Horai T. Okumura S. Nakagawa K. (2007) Recurrence patterns in patients with early stage non-small cell lung cancers undergoing positive pleural lavage cytology. Ann Thorac Surg 83: 197–202.
47. Shi H.Z. Liang Q.L. Jiang J. Qin X.J. Yang H.B. (2008) Diagnostic value of carcinoembryonic antigen in malignant pleural effusion: a meta-analysis. Respirology 13: 518–527.
48. Shield P.W. Koivurinne K. (2008) The value of calretinin and cytokeratin 5/6 as markers for mesothelioma in cell block preparations of serous effusions. Cytopathology 19: 218–223.
49. Shim H.S. Park I.K. Lee C.Y. Chung K.Y. (2009) Prognostic significance of visceral pleural invasion in the forthcoming (seventh) edition of TNM classification for lung cancer. Lung Cancer 65: 161–165.
50. Shim S.S. Lee K.S. Kim B.T. Choi J.Y. Shim Y.M. Chung M.J. (2006) Integrated PET/CT and the dry pleural dissemination of peripheral adenocarcinoma of the lung: diagnostic implications. J Comput Assist Tomogr 30: 70–76.
51. Shintani Y. Ohta M. Iwasaki T. Ikeda N. Kanou T. Tomita E. (2009) Intraoperative pleural lavage cytology after lung resection as an independent prognostic factor for staging lung cancer. J Thorac Cardiovasc Surg 137: 835–839.
52. Soh J. Toyooka S. Aoe K. Asano H. Ichihara S. Katayama H. (2006) Usefulness of EGFR mutation screening in pleural fluid to predict the clinical outcome of gefitinib treated patients with lung cancer. Int J Cancer 119: 2353–2358.
53. Taniguchi Y. Nakamura H. Miwa K. Adachi Y. Fujioka S. Haruki T. (2009) Prognostic significance of pleural lavage cytology after thoracotomy and before closure of the chest in lung cancer. Interact Cardiovasc Thorac Surg 9: 102–106.
54. Taube J.M. Askin F.B. Brock M.V. Westra W. (2007) Impact of elastic staining on the staging of peripheral lung cancers. Am J Surg Pathol 31: 953–956.
55. Tombesi P. Nielsen I. Tassinari D. Trevisani L. Abbasciano V. Sartori S. (2009) Transthoracic ultrasonography-guided core needle biopsy of pleural-based lung lesions: prospective randomized comparison between a Tru-cut-type needle and a modified Menghini-type needle. Ultraschall Med 30: 390–395.
56. Travis W.D. Brambilla E. Rami-Porta R. Vallieres E. Tsuboi M. Rusch V. (2008) Visceral pleural invasion: pathologic criteria and use of elastic stains: proposal for the 7th edition of the TNM classification for lung cancer. J Thorac Oncol 3: 1384–1390.
57. Traill Z.C. Davies R.J. Gleeson F.V. (2001) Thoracic computed tomography in patients with suspected malignant pleural effusions. Clin Radiol 56: 193–196.
58. Wang T. Qian X. Wang Z. Wang L. Yu L. Ding Y. (2009) Detection of cell-free BIRC5 mRNA in effusions and its potential diagnostic value for differentiating malignant and benign effusions. Int J Cancer 125: 1921–1925.
59. Webb W.R. Gatsonis C. Zerhouni E.A. Heelan R.T. Glazer G.M. Francis I.R. (1991) CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 178: 705–713.
60. Westfall D.E. Fan X. Marchevsky A.M. (2010) Evidence-based guidelines to optimize the selection of antibody panels in cytopathology: pleural effusions with malignant epithelioid cells. Diagn Cytopathol 38: 9–14.
61. Yoshida J. Nagai K. Asamura H. Goya T. Koshiishi Y. Sohara Y. (2009) Visceral pleura invasion impact on non-small cell lung cancer patient survival: its implications for the forthcoming TNM staging based on a large-scale nation-wide database. J Thorac Oncol 4: 959–963.
62. Young L.R. Franz D.N. Nagarkatte P. Fletcher C.D. Wikenheiser-Brokamp K.A. Galsky M.D. (2009) Utility of [18F]2-fluoro-2-deoxyglucose-PET in sporadic and tuberous sclerosis-associated lymphangioleiomyomatosis. Chest 136: 926–933.
63. Zhou W.B. Bai M. Jin Y. (2009) Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions. Int J Tuberc Lung Dis 13: 381–386.